• November 20, 2020
  • WTO

Japan | Designation of "Shitei Yakubutsu" (designated substances): Isotonitazene, MDMB-4en-PINACA, 2-methyl-AP-237


Your substances

None


Title of document
Designation of "Shitei Yakubutsu" (designated substances), based on the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devicees (hereinafter referred to as the "Act"). (1960, Law No.145) (1 page(s), in English)

Description
Proposal for the additional designatation of 3 substances as Shitei Yakubutsu, and their proper uses under the Act.

Notifying member: Japan

NotificationG/TBT/N/JPN/679

Objective tag
Other

Objective
In order to prevent the abuse of substances with probable effects on the central nervous system and to clarify the regulation under the Act, the MHLW designates such substances as Shitei Yakubutsu. Manufacture, import, sale,simple ownership and the use of Shitei Yakubutsu are banned except for the proper uses designated under the Act.

Documents


Agency responsible
Ministry of Health, Labour and Welfare (MHLW)


Timing:

  • Submission: 20/11/2020
  • Reception: 20/11/2020
  • Distribution: 20/11/2020
  • Final date for comments: N/A
  • Proposed date of adoption: N/A

                   

Related News

Loading...